Advertisement
Screener

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Graph

PBH Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $265.71M; Cost of revenue $129.52M; Operating expenses $83.67M; Income tax $9.36M.
  • 2026-03-31: Revenue $281.62M*; Cost of revenue $135.32M*; Operating expenses $70.81M*; Income tax $10.84M*.
  • 2025-12-31: Revenue $283.44M; Cost of revenue $126.08M; Operating expenses $74.88M; Income tax $15.12M.
  • 2025-09-30: Revenue $274.11M; Cost of revenue $122.53M; Operating expenses $71.91M; Income tax $26.92M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PBH revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product AndService Other$5.38MProduct$260.34MCough Cold And Allergy$21.30MDermatologicals$33.20MEye And Ear Care$32.98MGastrointestinal$62.20MOral Care$22.36MPain Relief$26.80MWellness Sleep Other$14.33MWomens Health$52.54MRevenue$265.71MCost of revenue$129.52MGross profit$136.19MOperating expenses$83.67MOperating income$52.52MOther income, net-$34.00KIncome tax$9.36MNet income$29.18M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PBH revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.InternationalOTC Healthcare$39.50MNorth AmericanOTC Healthcare$226.21MRevenue$265.71MCost of revenue$129.52MGross profit$136.19MOperating expenses$83.67MOperating income$52.52MOther income, net-$34.00KIncome tax$9.36MNet income$29.18M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2026-06-30$265.71M$129.52M$83.67M$9.36M$29.18M
2026-03-31$281.62M*$135.32M*$70.81M*$10.84M*$53.93M*
2025-12-31$283.44M$126.08M$74.88M$15.12M$46.70M
2025-09-30$274.11M$122.53M$71.91M$26.92M$42.21M
2025-06-30$249.53M$109.20M$68.58M$14.31M$47.47M
2024-12-31$290.32M$129.27M$69.09M$19.12M$61.03M
2024-09-30$283.79M$126.40M$73.04M$17.29M$54.38M
2024-06-30$267.14M$121.12M$73.98M$9.35M$49.07M
2023-12-31$282.74M$124.80M$71.11M$16.53M$53.05M
2023-09-30$286.32M$126.30M$71.77M$16.86M$53.56M
2023-06-30$279.31M$124.64M$69.48M$15.44M$53.28M
2022-12-31$275.52M$125.12M$63.22M$16.17M$51.95M
2022-09-30$289.27M$128.26M$76.63M$15.57M$51.02M
2022-06-30$277.06M$116.94M$73.11M$15.63M$55.27M
2021-12-31$274.47M$119.41M$72.47M$15.28M$50.22M
2021-09-30$276.23M$118.51M$79.15M$14.30M$45.33M
2021-06-30$269.18M$110.17M$67.67M$18.61M$57.76M
2020-12-31$238.79M$99.90M$65.44M$12.80M$40.87M
2020-09-30$237.42M$99.76M$64.76M$7.31M$44.59M
2020-06-30$229.39M$95.53M$53.75M$14.46M$43.71M
2020-03-31$251.24M$107.33M$69.99M$13.49M$37.05M
2019-12-31$241.55M$104.06M$61.09M$12.50M$38.06M
2019-09-30$238.07M$101.32M$67.40M$10.76M$33.25M
2019-06-30$232.15M$98.09M$62.58M$12.13M$33.92M
2019-03-31$241.03M$102.78M$291.69M-$39.76M-$139.27M
2018-12-31$241.41M$102.18M$61.69M$12.83M$38.17M
2018-09-30$239.36M$101.89M$66.55M$12.68M$30.84M
2018-06-30$253.98M$113.36M$68.14M$11.99M$34.47M
2018-03-31$255.97M$114.71M$164.35M-$12.88M-$39.69M
2017-12-31$270.62M$122.94M$63.78M-$257.15M$314.79M
2017-09-30$258.03M$113.93M$68.37M$18.62M$30.70M
2017-06-30$256.57M$113.10M$64.52M$18.93M$33.76M
2017-03-31$240.67M$110.49M$77.13M$7.71M$11.09M
2016-12-31$216.76M$92.22M$55.26M$19.09M$31.64M
2016-09-30$215.05M$91.09M$52.91M$18.03M$32.20M
2016-06-30$209.57M$87.98M$109.38M-$3.38M-$5.53M
2016-03-31$207.85M(m)$52.98M$10.67M$13.94M
2015-12-31$200.19M(m)$54.14M$15.19M$28.00M
2015-09-30$206.06M(m)$50.04M$17.43M$31.80M
2015-06-30$192.13M(m)$49.73M$14.00M$26.17M
2015-03-31$190.05M(m)$48.83M$13.68M$23.77M
2014-12-31$197.61M(m)$54.75M$12.24M$21.29M
2014-09-30$181.27M(m)$56.02M$11.86M$16.46M
2014-06-30$145.70M(m)$39.06M$11.42M$16.73M
2014-03-31$143.05M(m)$33.88M$10.70M$16.00M
2013-12-31$144.87M(m)$40.01M$1.06M$3.13M
2013-09-30$166.94M(m)$39.46M$4.53M$32.79M
2013-06-30$142.51M(m)$33.58M$12.84M$20.69M
2013-03-31$154.51M(m)$37.90M$11.14M$19.35M
2012-12-31$160.23M(m)$38.27M$7.80M$12.26M
2012-09-30$161.85M(m)$39.39M$12.25M$19.24M
2012-06-30$147.00M(m)$39.77M$9.33M$14.65M
2012-03-31$134.00M(m)$45.93M$815.00K-$15.00K
2011-12-31$106.25M(m)$31.49M$6.00M$9.51M
2011-09-30$105.54M(m)$24.50M$8.17M$12.95M
2011-06-30$95.30M(m)$22.63M$8.95M$14.77M
2010-12-31$90.61M(m)$30.99M$3.20M$2.18M
2010-09-30$78.30M(m)$18.75M$7.05M$11.02M
2010-06-30$71.24M(m)$17.31M$5.69M$9.61M

Revenue and expense 6 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2025-09-30$523.64M$231.73M$140.48M$41.23M$89.68M
2024-09-30$550.93M$247.52M$147.02M$26.63M$103.44M
2023-09-30$565.63M$250.93M$141.25M$32.29M$106.83M
2022-09-30$566.33M$245.20M$149.73M$31.20M$106.30M
2021-09-30$545.41M$228.68M$146.82M$32.92M$103.08M
2020-09-30$466.82M$195.29M$118.51M$21.77M$88.30M
2019-09-30$470.22M$199.41M$129.98M$22.89M$67.18M
2018-09-30$493.34M$215.24M$134.68M$24.67M$65.31M
2017-09-30$514.60M$227.03M$132.89M$37.55M$64.46M
2016-09-30$424.63M$179.07M$162.28M$14.65M$26.66M
2015-09-30$398.20M(m)$99.77M$31.43M$57.98M
2014-09-30$326.97M(m)$95.09M$23.28M$33.20M
2013-09-30$309.46M(m)$73.04M$17.38M$53.48M
2012-09-30$308.85M(m)$79.16M$21.58M$33.90M
2011-09-30$200.84M(m)$47.14M$17.13M$27.72M
2010-09-30$149.54M(m)$36.06M$12.74M$20.63M

Revenue and expense 9 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2025-12-31$807.09M$357.81M$215.36M$56.35M$136.37M
2024-12-31$841.24M$376.79M$216.11M$45.75M$164.48M
2023-12-31$848.37M$375.74M$212.35M$48.82M$159.88M
2022-12-31$841.86M$370.33M$212.95M$47.36M$158.25M
2021-12-31$819.88M$348.09M$219.29M$48.20M$153.29M
2020-12-31$705.60M$295.19M$183.95M$34.57M$129.17M
2019-12-31$711.77M$303.46M$191.07M$35.38M$105.23M
2018-12-31$734.75M$317.42M$196.38M$37.50M$103.47M
2017-12-31$785.21M$349.97M$196.68M-$219.61M$379.26M
2016-12-31$641.39M$271.29M$217.54M$33.74M$58.30M
2015-12-31$598.39M(m)$153.91M$46.61M$85.97M
2014-12-31$524.58M(m)$149.84M$35.52M$54.49M
2013-12-31$454.33M(m)$113.05M$18.43M$56.61M
2012-12-31$469.08M(m)$117.44M$29.39M$46.16M
2011-12-31$307.09M(m)$78.63M$23.13M$37.23M
2010-12-31$240.15M(m)$67.05M$15.95M$22.81M

Revenue and expense 12 month

Period endRevenueCost of revenueOperating expensesIncome taxNet income
2026-03-31$1.09B$493.13M$286.17M$67.19M$190.30M
2025-03-31$1.14B$503.30M$297.69M$69.58M$214.60M
2024-03-31$1.13B$500.91M$282.02M$66.69M$209.30M
2023-03-31$1.13B$502.43M$647.71M-$11.61M-$82.30M
2022-03-31$1.09B$466.17M$290.73M$57.08M$205.40M
2021-03-31$943.37M$395.89M$250.07M$39.43M$164.68M
2020-03-31$963.01M$410.79M$261.07M$48.87M$142.28M
2019-03-31$975.78M$420.20M$488.07M-$2.25M-$35.80M
2018-03-31$1.04B$464.67M$361.03M-$232.48M$339.57M
2017-03-31$882.06M$381.77M$294.64M$41.45M$69.39M
2016-03-31$806.25M$339.04M$206.90M$57.28M$99.91M
2015-03-31$714.62M(m)$198.66M$49.20M$78.26M
2014-03-31$597.38M(m)$146.94M$29.13M$72.61M
2013-03-31(m)(m)$151.85M$40.53M$65.50M
2012-03-31$441.08M(m)$124.56M$23.95M$37.21M
2011-03-31$336.51M(m)$94.73M$19.35M$29.22M
2010-03-31$292.60M(m)$75.12M$20.66M$32.12M

Similar stocks

Stock NameCountryMarket CapPE Ratio
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Zai Lab Ltd (ZLAB)$2.241B-113.34
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05